Literature DB >> 1643304

Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination.

T K Young1, S Mirdad.   

Abstract

A cross-sectional survey of 701 Indian children aged 1-15 in five northern Canadian communities showed that 82% had a documented history of BCG vaccination while only 78% had a visible scar. The prevalence of 5 mm or more induration on Mantoux testing varied from 6 to 26%. Multiple logistic regression indicated that community, age, past use of isoniazid and time since the last Mantoux test were positive predictors of sensitivity. The presence of a BCG scar and the number of past vaccinations were not significantly associated but the elapsed time since the last BCG was negatively associated with a positive reaction. Overcrowding, nutritional status and past history of household and community contact with an active case of tuberculosis were also investigated but their independent effect could not be demonstrated. Despite the presence of mass BCG vaccination in this population, tuberculin testing is still a useful tool in assessing the risk of infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643304     DOI: 10.1016/0962-8479(92)90062-O

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Diagnostic value of interferon- gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis.

Authors:  Rajeshwar Dayal; Vikas Verma; B Sharma; G Kumar; N Kumar; R Gupta; V M Katoch; Beenu Joshi; D S Chauhan
Journal:  Indian J Pediatr       Date:  2011-06-25       Impact factor: 1.967

2.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

3.  The value of counting BCG scars for interpretation of tuberculin skin tests in a tuberculosis hyperendemic shantytown, Peru.

Authors:  M Saito; C T Bautista; R H Gilman; A Bowering; M Z Levy; C A Evans
Journal:  Int J Tuberc Lung Dis       Date:  2004-07       Impact factor: 2.373

Review 4.  BCG vaccination in India and tuberculosis in children: newer facets.

Authors:  P M Udani
Journal:  Indian J Pediatr       Date:  1994 Sep-Oct       Impact factor: 1.967

5.  Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models.

Authors:  José I Villate; Berta Ibáñez; Valentín Cabriada; José I Pijoán; Jorge Taboada; Arantza Urkaregi
Journal:  BMC Public Health       Date:  2006-09-28       Impact factor: 3.295

6.  Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.

Authors:  Roger H Brookes; Philip C Hill; Patrick K Owiafe; Hannah B Ibanga; David J Jeffries; Simon A Donkor; Helen A Fletcher; Abdulrahman S Hammond; Christian Lienhardt; Richard A Adegbola; Helen McShane; Adrian V S Hill
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.